Glenmark Pharma share price added 2 percent after the company

Glenmark

Glenmark Pharma share price added 2 percent after the company entered into an exclusive licensing agreement with Menarini.
Glenmark Pharmaceuticals announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive

licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal spray Ryaltris across 33

countries in Europe, including the Balkan region, the company said in an exchange filing.

News Source:- Moneycontrol

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from bigprofitbuzz.com.

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button